This page lists the cardiothoracic & vascular surgery hospitals in our directory offering Bentall Procedure in Bengaluru, India, including Narayana Health, Manipal Hospitals, Medicover Hospital, Bangalore, Gleneagles Hospitals, Bengaluru and others. Each listing links through to the hospital's full profile page.
Ask us about bentall procedure in Bengaluru, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 10 accredited hospitals for Cardiothoracic & Vascular Surgery in Bengaluru, India
Featured🇮🇳 Narayana Health
Ranks #1 in this list by listed rating (4.8/5 from 1750 reviews).
🇮🇳 Manipal Hospitals
Ranks #2 in this list by listed rating (4.7/5 from 1450 reviews).
🇮🇳 Medicover Hospital, Bangalore
Ranks #3 in this list by listed rating (4.7/5 from 68 reviews).
🇮🇳 Gleneagles Hospitals, Bengaluru
Ranks #4 in this list by listed rating (4.7/5 from 142 reviews).
🇮🇳 Manipal Hospital Malleshwaram (Northside)
Ranks #5 in this list by listed rating (4.6/5 from 71 reviews).
🇮🇳 Manipal Hospital, Old Airport Road
Ranks #6 in this list by listed rating (4.5/5 from 87 reviews).
🇮🇳 Manipal Hospital Yeshwanthpur (Columbia Asia)
Ranks #7 in this list by listed rating (4.5/5 from 98 reviews).
🇮🇳 Manipal Hospital Millers Road (Vikram Hospital)
Ranks #8 in this list by listed rating (4.4/5 from 74 reviews).
🇮🇳 Apollo Hospital, Bannerghatta Road
Ranks #9 in this list by listed rating (4.2/5 from 25 reviews).
🇮🇳 Fortis Hospital, Bannerghatta Road
Ranks #10 in this list by listed rating (4.2/5 from 58 reviews).
How we selected these hospitals
A hospital appears on this page when Cardiothoracic & Vascular Surgery is among its listed specialties and it is located in Bengaluru, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Bentall Procedure in Bengaluru, India?
Choosing the right hospital for bentall procedure is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include cardiothoracic & vascular surgery rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Bentall Procedure
The Bentall Procedure is a complex open-heart operation that simultaneously replaces the aortic root, the aortic valve, and the ascending aorta, typically using a composite valved conduit, and is considered the definitive surgical treatment for conditions such as Marfan syndrome-related aortic root aneurysm, aortic root dissection (Type A), and severe aortic valve disease with root involvement. Contemporary series from high-volume cardiac centers report operative survival rates exceeding 95% for elective cases, with long-term outcomes comparable to or better than isolated valve replacement when the root pathology is addressed comprehensively. GAF Healthcare connects international patients with JCI- and NABH-accredited centers in India and JCI- and DHA-licensed hospitals in Dubai and Abu Dhabi, where board-certified cardiothoracic surgeons perform over 200 Bentall Procedures annually, combining world-class surgical expertise with cost structures that are 40–65% below Western benchmarks. Hospital Stay: 10–14 days (including 2–4 days in cardiac ICU followed by 7–10 days in monitored ward) • Total Stay in Country (Fit-to-Fly): 6–8 weeks (international long-haul flight clearance requires stable anticoagulation, wound healing, and cardiology sign-off) • Success Rate: 95–97% (elective operative survival at high-volume centers; 10-year survival approximately 70–75%)
Clinical Overview
The aortic root — the segment of the aorta that originates directly from the left ventricle and houses the coronary ostia and the aortic valve annulus — is uniquely vulnerable to aneurysmal dilation, dissection, and valvular dysfunction. When the aortic root diameter exceeds 5.0–5.5 cm (or 4.5 cm in patients with Marfan syndrome, Loeys-Dietz syndrome, or bicuspid aortic valve disease), the risk of acute aortic dissection or rupture increases exponentially, carrying a mortality rate of 1–2% per hour without emergency surgery. Concomitant aortic valve pathology — stenosis, regurgitation, or endocarditis-related destruction — may render isolated valve replacement insufficient if the structural integrity of the root itself is compromised. The Bentall Procedure, first described by Hugh Bentall and Antony De Bono in 1968 and subsequently refined over five decades, addresses this combined pathology in a single operative field. The surgeon excises the diseased aortic root and ascending aorta, reimplants both coronary arteries (the modified Cabrol technique or the preferred 'button Bentall' technique using coronary buttons), and seats a composite graft consisting of a prosthetic tubular Dacron graft sewn to either a mechanical bileaflet valve (St. Jude Medical, On-X) or a bioprosthetic tissue valve (Carpentier-Edwards PERIMOUNT, INSPIRIS RESILIA). The choice between mechanical and tissue valves is individualized based on patient age, lifestyle, bleeding risk, and desire for lifelong anticoagulation. The standard of care at GAF Healthcare partner institutions incorporates cardiopulmonary bypass with moderate hypothermic circulatory arrest (18–22°C) when the arch requires inspection or replacement, cerebral perfusion protection via antegrade selective cerebral perfusion through cannulation of the right axillary artery, intraoperative transesophageal echocardiography (TEE) for real-time hemodynamic monitoring and graft assessment, and Cell Saver autotransfusion systems to minimize allogenic blood exposure. Postoperative management follows ESC/ACC/AHA aortic disease guidelines, with early extubation protocols (fast-track cardiac anesthesia), goal-directed hemodynamic therapy, and bridging anticoagulation with unfractionated heparin before transition to warfarin (target INR 2.5–3.5 for mechanical valves) or direct oral anticoagulants where applicable.
Who is a Candidate?
• ELIGIBILITY — Aortic root aneurysm with root diameter ≥ 5.5 cm in non-syndromic patients (CT angiography or MRI confirmed) • ELIGIBILITY — Aortic root diameter ≥ 4.5–5.0 cm in patients with Marfan syndrome, Loeys-Dietz syndrome, Ehlers-Danlos syndrome (vascular type), or bicuspid aortic valve with associated connective tissue disorder • ELIGIBILITY — Acute or chronic Type A aortic dissection involving the aortic root, requiring emergency or urgent root replacement • ELIGIBILITY — Severe aortic valve disease (aortic stenosis with mean gradient > 40 mmHg or aortic regurgitation with LVESD > 50 mm) in the presence of root dilation ≥ 4.5 cm, making isolated valve replacement insufficient • ELIGIBILITY — Aortic root endocarditis with annular abscess or pseudoaneurysm formation, where valve-sparing or isolated repair is not anatomically feasible • ELIGIBILITY — Patients with a prior aortic valve replacement who develop subsequent root aneurysm (redo Bentall) • REQUIRED DIAGNOSTICS — Contrast-enhanced CT angiography of the full aorta (from root to iliacs) for precise diameter measurement, dissection mapping, and surgical planning • REQUIRED DIAGNOSTICS — Transthoracic echocardiogram (TTE) and intraoperative transesophageal echocardiogram (TEE) to assess ventricular function, valve morphology, and regurgitation severity • REQUIRED DIAGNOSTICS — Cardiac MRI (CMR) for patients with equivocal CT findings or to assess myocardial fibrosis and aortic flow quantification • REQUIRED DIAGNOSTICS — Coronary angiography or CT coronary angiography to rule out significant CAD requiring concomitant CABG • REQUIRED DIAGNOSTICS — Genetic testing (FBN1, TGFBR1/2, COL3A1) for patients under 50 with root aneurysm to identify heritable thoracic aortic disease syndromes • REQUIRED DIAGNOSTICS — Preoperative risk stratification using EuroSCORE II and the STS Predicted Risk of Mortality (PROM) scoring systems • REQUIRED DIAGNOSTICS — Complete blood count, coagulation panel (PT/INR, aPTT), renal function (eGFR), liver function, HbA1c (diabetic patients), and group-and-screen • CONTRAINDICATIONS (RELATIVE) — Severely reduced left ventricular ejection fraction (LVEF < 20%) without reversible etiology; surgical risk must be weighed against heart failure optimization or bridging with LVAD • CONTRAINDICATIONS (RELATIVE) — Severe, uncorrected coagulopathy or active bleeding disorder • CONTRAINDICATIONS (RELATIVE) — Advanced renal failure (eGFR < 15 mL/min) not on dialysis — requires nephrology co-management and individualized risk discussion • CONTRAINDICATIONS (RELATIVE) — Active systemic infection unrelated to the aortic root (surgery should be deferred until infection is controlled) • CONTRAINDICATIONS (ABSOLUTE) — Patient refusal of surgical intervention with full understanding of rupture/dissection risk (medical management with beta-blockers and ARBs such as losartan is continued in this scenario)
Treatment Options & Approaches
STANDARD BENTALL PROCEDURE (COMPOSITE VALVE GRAFT — MECHANICAL): The classical and most widely performed approach uses a composite graft pre-sewn or hand-sewn with a bileaflet mechanical valve (most commonly On-X or St. Jude Medical Masters Series). The coronary arteries are detached from the native root as 'buttons' of aortic wall tissue and reimplanted directly into pre-cut holes in the Dacron graft — the 'button Bentall' technique, which has supplanted the original inclusion (wrap) technique due to lower risk of late pseudoaneurysm formation. This approach requires lifelong anticoagulation with warfarin (target INR 2.5–3.5). It is preferred for younger patients (< 60 years) who have no anticoagulation contraindications and desire durability without reoperation risk. BIOPROSTHETIC COMPOSITE GRAFT (TISSUE VALVE BENTALL): For patients over 65 years, women of childbearing age, those with occupational bleeding risk, or patients who decline lifelong anticoagulation, a bioprosthetic tissue valve (Carpentier-Edwards PERIMOUNT Magna Ease, INSPIRIS RESILIA with anti-calcification polymer treatment, or Medtronic Mosaic) is incorporated into the composite graft. The INSPIRIS RESILIA valve features VFit technology, enabling future transcatheter valve-in-valve (TAVR-in-surgical-valve) implantation if structural valve deterioration occurs — a major strategic advantage that eliminates the need for high-risk redo open surgery in elderly patients. VALVE-SPARING ROOT REPLACEMENT (DAVID PROCEDURE — ALTERNATIVE): For patients under 50 with a structurally normal, pliable aortic valve (tri-leaflet, leaflet height > 17 mm, no commissural fusion) who wish to avoid prosthetic valve and anticoagulation altogether, the David reimplantation procedure (David V technique) is offered at GAF Healthcare partner centers. The native aortic valve is preserved and resuspended within a Dacron tube graft, restoring aortic root geometry. Freedom from reoperation at 10 years exceeds 90% in experienced hands. This is not a Bentall Procedure per se but is the direct alternative and is evaluated case-by-case. MINIMALLY INVASIVE / MINISTERNOTOMY APPROACH: Selected centers in India and the UAE now offer the Bentall Procedure through an upper (partial) ministernotomy (J-sternotomy or upper mini-sternotomy), limiting the incision to the upper third of the sternum. This approach reduces wound complications, blood loss, ICU stay, and postoperative pain while preserving the mechanical advantages of full sternotomy access. Patient selection requires preoperative CT planning to confirm root accessibility. Not suitable for redo sternotomy cases or those requiring concomitant mitral or tricuspid surgery. CONCOMITANT PROCEDURES: The Bentall Procedure is frequently combined with: (1) Total arch replacement with elephant trunk technique for aortic arch aneurysm; (2) CABG for concurrent significant coronary artery disease (identified on preoperative coronary angiography); (3) Mitral valve repair or replacement for functional or organic mitral regurgitation; (4) Tricuspid annuloplasty for secondary tricuspid regurgitation. Each addition increases operative time and CPB duration and is factored into individualized risk scoring. HYBRID AORTIC APPROACHES: For patients with extended aortic pathology (root + arch + descending aorta), a staged hybrid approach is used: surgical Bentall + open arch repair (stage 1), followed by thoracic endovascular aortic repair (TEVAR) for the descending component (stage 2), minimizing the physiological insult of a single prolonged operation. ANESTHESIA & PERFUSION TECHNOLOGIES: All GAF Healthcare partner sites utilize: (1) moderate hypothermic circulatory arrest (18–22°C) with antegrade selective cerebral perfusion (ASCP) via the right axillary artery to protect the brain during aortic clamping; (2) del Nido cardioplegia for superior myocardial protection; (3) Cell Saver autologous blood conservation; (4) continuous intraoperative TEE; and (5) near-infrared spectroscopy (NIRS) cerebral oximetry for real-time neurological monitoring.
Recovery
PRE-ARRIVAL PHASE (2–4 weeks before travel): • GAF Healthcare case manager reviews CT angiography, echo reports, and surgical history to match patient with appropriate surgeon and hospital • Telemedicine consultation with operating cardiothoracic surgeon to discuss valve choice (mechanical vs. tissue), operative risk (EuroSCORE II / STS PROM), and expected outcomes • e-Medical Visa application facilitated by GAF Healthcare (India) or tourist/entry visa guidance (UAE — UAE nationals and many GCC passport holders enter visa-free or on visa-on-arrival) • Travel insurance with cardiac surgical cover obtained; anticoagulation instructions issued if patient is on warfarin or antiplatelet therapy • Preadmission blood work, ECG, and pulmonary function testing arranged locally or on arrival DAY 1–2 (ADMISSION & PREOPERATIVE WORKUP): • Hospital admission; complete in-hospital workup: CT angiography review, TTE/TEE, coronary angiography or CT coronary angiography, full labs, anesthesia consultation • Surgeon reviews imaging personally; final decision on valve type, conduit size, and need for arch work or CABG • Informed consent in patient's preferred language (GAF Healthcare medical translator present) • Bowel preparation, chest physiotherapy orientation, and cardiothoracic ICU familiarization DAY 3 — THE PROCEDURE (6–9 hours operative time): • General endotracheal anesthesia with TEE probe placed before skin incision • Full or partial (ministernotomy) median sternotomy; cannulation of the right femoral artery/axillary artery and right atrium for cardiopulmonary bypass • Systemic cooling to 18–22°C; aortic cross-clamping; del Nido or cold blood cardioplegia arrest • Excision of the diseased aortic root and native valve; coronary button mobilization • Composite graft seated at the aortic annulus with pledgeted horizontal mattress sutures (annular reinforcement with felt strips in patients with Marfan syndrome) • Left coronary button reimplantation; right coronary button reimplantation • Distal anastomosis of the Dacron graft to the transected ascending aorta • Rewarming; weaning from CPB; intraoperative TEE confirming valve function, coronary perfusion, and absence of paravalvular leak • Chest closure with sternal wires; wound closure DAY 3–5 (CARDIAC ICU — 2–4 DAYS): • Mechanical ventilation typically 4–12 hours; early extubation protocol (fast-track cardiac anesthesia) • Invasive hemodynamic monitoring: arterial line, pulmonary artery catheter or PiCCO; continuous cardiac output monitoring • Anticoagulation initiated: unfractionated heparin infusion from day 1 postoperatively targeting aPTT 60–80 seconds • Pain management: IV opioid PCA transitioning to oral multimodal analgesia • Chest physiotherapy and incentive spirometry from extubation • Daily ECG, chest X-ray, serum lactate, troponin trend DAY 5–14 (MONITORED WARD): • Warfarin initiated (mechanical valve patients) with INR targeting 2.5–3.5; heparin bridge until therapeutic; antiplatelet therapy per surgeon protocol for tissue valve patients • Ambulation progressively from day 5 (corridor walking with physiotherapist) • Echocardiogram on day 7 to assess valve function, pericardial effusion, and ventricular recovery • Dietary counseling on vitamin K-consistent diet (mechanical valve warfarin patients); anticoagulant patient education • Wound care for sternal incision; sternal precautions education (no lifting > 2 kg for 6–8 weeks) • Discharge planning with GAF Healthcare case manager: follow-up clinic appointments, pharmacy supply of anticoagulants for journey home WEEKS 2–8 (POST-DISCHARGE IN-COUNTRY RECOVERY): • Patients must remain within reasonable distance of the treating hospital for a minimum of 4 weeks post-discharge for mandatory follow-up: wound check at week 2, INR monitoring (2–3x per week initially), and cardiology review at weeks 2 and 4 • Cardiac rehabilitation: supervised walking program, respiratory physiotherapy, progressive aerobic conditioning • Repeat TTE at week 4 to confirm stable valve function and healing WEEK 6–8 (FIT-TO-FLY ASSESSMENT): • Cardiothoracic surgeon and cardiologist jointly assess: stable anticoagulation (INR in therapeutic range for > 2 consecutive weeks), fully healed sternotomy, no signs of mediastinitis or pericardial effusion, LVEF ≥ 45%, and absence of arrhythmia requiring in-hospital management • Written fit-to-fly certificate issued; compression stocking prescription for long-haul flight; in-flight anticoagulation instructions provided • GAF Healthcare arranges wheelchair assistance at airport, in-flight medication pack, and coordination with home country cardiologist for continuity of care LONG-TERM RECOVERY MILESTONES: • 8 weeks: Return to sedentary or desk-based work • 12 weeks: Driving (subject to local regulations and surgeon clearance) • 3–6 months: Return to moderate physical activity; annual aortic imaging (CT or MRI) for remnant aorta surveillance • Lifelong: Annual cardiology follow-up, INR monitoring (mechanical valve), echocardiography every 1–2 years, and MRI/CT of the entire aorta every 3–5 years to monitor for disease progression in the native aorta
Risks to be aware of
The Bentall Procedure, while life-saving, carries procedural risks that patients must understand transparently. Operative mortality for elective cases at high-volume centers ranges from 2–5%; emergency surgery for acute Type A dissection carries higher mortality of 10–20% even in expert hands. Neurological complications — including stroke (2–5%) and transient neurocognitive dysfunction ('pump head', 15–30% at 1 month but largely reversible by 6 months) — are reduced by antegrade selective cerebral perfusion and careful perfusion management. Coronary ostial complications from button reimplantation, including kinking or avulsion, can precipitate perioperative myocardial infarction (< 2% in experienced centers). Bleeding requiring re-exploration occurs in 3–5% of cases; coagulopathy is managed with thromboelastography-guided (TEG) transfusion protocols. Acute kidney injury requiring temporary renal replacement therapy occurs in 5–8%; permanent dialysis dependence is uncommon (< 1%) in patients with normal preoperative renal function. Sternal wound infection or mediastinitis (1–3%) is managed with vacuum-assisted closure (VAC) therapy and targeted antibiotics. Late complications include: structural valve deterioration of bioprosthetic valves (freedom from reoperation at 15 years approximately 70–80%); mechanical valve thrombosis if INR control is inadequate (annual risk < 0.5% with optimal anticoagulation); paravalvular leak (< 1% requiring reoperation at high-volume centers); and pseudoaneurysm formation at anastomotic sites (reduced by the button technique versus the original inclusion wrap). Patients with Marfan syndrome face ongoing risk of disease progression in the native descending aorta, necessitating lifelong aortic surveillance imaging. All risks are discussed in detail during the pre-operative telemedicine consultation and formal informed consent process with GAF Healthcare's partner surgeons.
Why GAF Healthcare
GAF Healthcare provides comprehensive end-to-end non-medical coordination designed specifically for international cardiac surgical patients requiring the Bentall Procedure. e-MEDICAL VISA — INDIA: For patients traveling to India, GAF Healthcare's visa coordination team prepares and submits the e-Medical Visa application through the Indian government's official portal, including the mandatory sponsor letter from the accredited hospital, a physician referral letter, and all supporting medical documents. The e-Medical Visa permits a 60-day stay (extendable in-country if recovery requires additional time) and allows two attendants (family members or caregivers) to travel on e-Medical Attendant Visas simultaneously. Processing typically takes 3–5 business days and is tracked by the GAF Healthcare team. VISA — UAE (DUBAI / ABU DHABI): Passport holders from over 50 countries including the UK, EU nations, USA, Canada, and Australia receive free 30- or 90-day tourist/visit visas on arrival in the UAE. GCC nationals require no visa. For other nationalities, GAF Healthcare coordinates medical visit visa applications through the hospital's international patient office, which is licensed by the Dubai Health Authority (DHA) or Department of Health Abu Dhabi (DoH). Visa extensions for recovery periods are arranged directly by the hospital's visa desk. AIRPORT TRANSFERS: Dedicated air-conditioned medical transport — not shared taxi — meets patients at Indira Gandhi International (Delhi), Chhatrapati Shivaji Maharaj (Mumbai), or Kempegowda (Bangalore) airports in India, and at Dubai International (DXB) or Abu Dhabi International (AUH) in the UAE. Transfer vehicles are equipped with a portable oxygen supply and accompanied by a trained medical escort for cardiac patients traveling post-discharge. MEDICAL TRANSLATION & INTERPRETATION: GAF Healthcare assigns a dedicated bilingual patient coordinator who accompanies the patient during surgical consent discussions, pre-operative ward rounds, ICU family briefings, and discharge counseling. Languages available include Arabic, Russian, French, Bengali, Swahili, Amharic, Pashto, and others on request. All discharge summaries, anticoagulation instructions, and follow-up protocols are provided in the patient's preferred language. ATTENDANT ACCOMMODATION: GAF Healthcare pre-books serviced apartments or hospital-approved guest houses within 5–10 minutes of the treating hospital for the patient's family member or attendant, at negotiated rates substantially below retail. Options range from standard furnished apartments to premium hotel suites depending on budget. Meal delivery, laundry services, and local SIM cards are arranged as part of the welcome package. During ICU stay, a designated family waiting lounge with regular nurse-to-family briefings is coordinated through the hospital's international patient services desk. POST-DISCHARGE COORDINATION: Before departure, GAF Healthcare's case manager provides the patient's home-country cardiologist with a comprehensive discharge bundle: operative report, valve type and size certificate (essential for future medical care and airport security screening for mechanical valve patients), INR diary, anticoagulant bridging plan for the flight, and a 12-month surveillance imaging schedule. A 24/7 WhatsApp helpline connects the patient to a GAF Healthcare nurse coordinator for the first 90 days after returning home.
Common questions about Bentall Procedure
What is the cost of the Bentall Procedure in India versus the UAE?
How long do I need to stay in the country before I am fit to fly home after the Bentall Procedure?
What is the success rate of the Bentall Procedure?
How GAF Healthcare Assists in Choosing the Best Hospital for Bentall Procedure in Bengaluru, India
Discover the Top Hospitals for Bentall Procedure in Bengaluru, India
This page lists 10 accredited cardiothoracic & vascular surgery hospitals in Bengaluru, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about bentall procedure in Bengaluru, India
How many cardiothoracic & vascular surgery hospitals are listed in Bengaluru, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there cardiothoracic & vascular surgery hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for bentall procedure in Bengaluru, India.
Contact us to report an inaccuracy on this page.